November 02, 2025

Get In Touch

IMA Slams Dr Harsh Vardhan For Endorsing Patanjali'S Coronil As Treatment For COVID-19

New Delhi: The Indian Medical Association (IMA) on Monday came down heavily on Union Health Minister Harsh Vardhan for endorsing Patanjali's Coronil which was relaunched as treatment of COVID-19, a claim questioned by the World Health Organisation.
"As per the code of the Medical Council of India, which binds the code of conduct of every modern medical doctor, no doctor can promote any drug. However, it is surprising that the health minister, who himself is a modern medicine doctor, was found promoting the drug," the association said.
Also Read: Ayurveda medicine market progressed by 50 to 90 percent post-COVID: Dr Harsh Vardhan
The IMA said that the "false and fabricated" projection of an "unscientific" medicine made in the presence of the country's health minister, later rejected by the WHO is a slap and insult to the whole nation.
The association questioned the Union Health Minister's ethics as a physician and health minister of the country for making an appearance at the launch event organized by Ayurvedic drug firm Patanjali run by Yoga guru Ramdev.
The association mentioned a clause under the National Medical Commission (NMC, erstwhile MCI) which prohibits a physician from promoting a drug.
"Under section 6:1:1, a physician shall not give to any person, whether for compensation or otherwise, any approval, recommendation, endorsement, certificate, report or statement with respect of any drug, medicine, with his name, signature, or photograph in any form or manner of advertising through any mode nor shall he boast of cases, operations, cures or remedies or permit the publication of report thereof through any mode," the IMA specified.
The association said that it will write to the NMC for seeking suo moto explanation for Harsh Vardhan's "blatant disrespect to the code of conduct of Medical council of India".
In a grand launch event held on February 19, where Harsh Vardhan and Union Transport Minister Nitin Gadkari were also present, Patanjali had billed Coronil tablets as the "first evidence-based medicine for COVID-19".
In the event, Baba Ramdev, co-founder of the ayurvedic firm had claimed that the ayurvedic medicine has received certification from the World Health Organization (WHO), which was later denied by the UN body in an official tweet.
At the launch event of Coronil, Patanjali said, "Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme."
Hours later, the WHO South-East Asia tweeted: "WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment of COVID-19."
Now when the WHO rejected the claims, Patanjali's CEO Acharya Balkrishna made a clarification on Twitter. He wrote: "We want to clarify to avoid confusion that our WHO GMP compliant COPP certificate to Coronil is issued by DCGI, Government of India".
Balkrishna also added that "WHO does not approve or disapprove of any drugs. Instead, it works for building a better and healthier future for people all over the world."
Also Read:Not reviewed any traditional drug for treating Covid-19: WHO clarifies on Patanjali's Coronil Certification claim

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!